Slide 1: Earnings Summary Fourth Quarter 2021
Earnings Summary Fourth Quarter 2021 February 1, 2022
Slide 2: Safe Harbor
Safe Harbor This presentation contains forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. Thes
Slide 3: Fourth Quarter 2021 Financial Summary
Fourth Quarter 2021 Financial Summary $0.87 $635M +23% 1 DILUTED GAAP EPS +38% REVENUE $0.96 2 +35% DILUTED NON-GAAP EPS 3 $160M +41% 25.1% +320 bps OPERATING INCOME OPERATING MARGIN 3 $177M 2 +39% 27.8% +330 2 bps ADJUSTED OPERATING INCOME ADJUSTED OPERATING MARGIN 1. All growth data on this slide
Slide 4: 2021 Financial Summary
2021 Financial Summary $3.00 $2.3B +24% 1 DILUTED GAAP EPS +39% REVENUE $3.44 2 +35% DILUTED NON-GAAP EPS 3 $552M +40% 24.0% +270 bps OPERATING INCOME OPERATING MARGIN 3 $609M 2 +33% 26.5% +180 2 bps ADJUSTED OPERATING INCOME ADJUSTED OPERATING MARGIN 1. All growth data on this slide is year-on-year
Slide 5: Summary – Consolidated Statement of Operations (GAAP)
Summary – Consolidated Statement of Operations (GAAP) 4Q21 over 4Q21 over $ in millions, except per share data 4Q21 4Q21 Guidance 3Q21 4Q20 4Q20 3Q21 Net Revenue $635.2 $580 - $600 $579.5 $517.6 22.7% 9.6% Gross Margin 46.5% 45.6% 44.6% Operating Expenses $135.5 $128 - $130 $124.8 $117.6 15.2% 8.6%
Slide 6: Summary – Consolidated Statement of Operations (Non-GAAP)
Summary – Consolidated Statement of Operations (Non-GAAP)1 4Q21 over 4Q21 over $ in millions, except per share data 4Q21 4Q21 Guidance 3Q21 4Q20 4Q20 3Q21 Net Revenue $635.2 $580 - $600 $579.5 $517.6 22.7% 9.6% Adjusted Gross Margin – as a % of 46.5% 45.6% 44.6% Net Sales2 Non-GAAP Operating Expense
Slide 7: Summary – Consolidated Statement of Operations (GAAP)
Summary – Consolidated Statement of Operations (GAAP) Year Ended Year Ended $ in millions, except per share data December 31, 2021 December 31, 2020 Year-over-Year Net Revenue $2,298.9 $1,859.3 23.6% Gross Margin 46.1% 45.7% Operating Expenses $507.9 $454.3 11.8% Operating Income $551.8 $395.4 39.5%
Slide 8: Summary – Consolidated Statement of Operations (Non-GAAP)
Summary – Consolidated Statement of Operations (Non-GAAP)1 Year Ended Year Ended December 31, December 31, $ in millions, except per share data 2021 2020 Year-over-Year Net Revenue $2,298.9 $1,859.3 23.6% Adjusted Gross Margin – as a % of Net Sales2 46.1% 45.7% Non-GAAP Operating Expenses3 $451.0 $3
Slide 9: Specialty Chemicals and Engineered Materials (SCEM)
Specialty Chemicals and Engineered Materials (SCEM) 4Q21 Highlights 4Q21 over 4Q21 over Sales growth was primarily driven by $ in millions 4Q21 3Q21 4Q20 4Q20 3Q21 advanced deposition materials, formulated Net Revenue $188.0 $176.4 $168.6 11.5% 6.6% cleans and selective etch chemistries. –––––– Segm
Slide 10: Microcontamination Control (MC)
Microcontamination Control (MC) 4Q21 Highlights 4Q21 over 4Q21 over Sales growth was strong across all product $ in millions 4Q21 3Q21 4Q20 4Q20 3Q21 lines 2021, especially in liquid filtration, Net Revenue $258.9 $225.9 $205.6 25.9% 14.6% demonstrating strong traction in advanced logic and memory n
Slide 11: Advanced Materials Handling (AMH)
Advanced Materials Handling (AMH) 4Q21 Highlights 4Q21 over 4Q21 over $ in millions 4Q21 3Q21 4Q20 4Q20 3Q21 Net Revenue $197.7 $186.2 $151.7 30.3% 6.2% Year-on-year sales growth was strongest in wafer handling and fluid handling. Sales Segment Profit $45.3 $40.5 $34.3 32.0% 11.9% of Aramus products
Slide 12: Summary – Balance Sheet Items
Summary – Balance Sheet Items $ in millions 4Q21 3Q21 4Q20 $ Amount % Total $ Amount % Total $ Amount % Total Cash & Cash Equivalents $402.6 12.6% $475.8 15.8% $580.9 19.9% Accounts Receivable, net $347.4 10.9% $315.1 10.5% $264.4 9.1% Inventories $475.2 14.9% $429.0 14.2% $323.9 11.1% Net PP&E $654
Slide 13: Cash Flows
Cash Flows Year ended $ in millions 4Q21 3Q21 4Q20 December 31, 2021 Beginning Cash Balance $475.8 $401.0 $448.0 $580.9 Cash provided by operating activities 116.0 149.5 204.0 $400.5 Capital expenditures (76.6) (48.9) (52.2) ($210.6) Proceeds from revolving credit facilities and long- term debt 50.0
Slide 14: Outlook
Outlook GAAP $ in millions, except per share data 1Q22 Guidance 4Q21 Actual 3Q21 Actual Net Revenue $630 - $650 $635.2 $579.5 Operating Expenses $150 - $152 $135.5 $124.8 Net Income $111- $118 $118.2 $117.5 Diluted Earnings per Common Share $0.81- $0.86 $0.87 $0.86 Non-GAAP $ in millions, except per
Slide 15: Entegris trademarks notice
Entegris®, the Entegris Rings Design®, and other product names are trademarks of Entegris, Inc. as listed on entegris.com/trademarks. All product names, logos, and company names are trademarks or registered trademarks of their respective owners. Use of them does not imply any affiliation, sponsorshi
Slide 16: Appendix
Appendix Entegris
Slide 17: Reconciliation of GAAP Gross Profit to Adjusted Gross Profit
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit Three months ended Twelve months ended $ in thousands December 31, 2021 December 31, 2020 October 2, 2021 December 31, 2021 December 31, 2020 Net sales $635,204 $517,594 $579,493 $2,298,893 $1,859,313 Gross profit-GAAP $295,090 $230,872 $2
Slide 18: Reconciliation of GAAP Operating Expenses and Tax Rate to Non-GAAP
Reconciliation of GAAP Operating Expenses and Tax Rate to Non-GAAP Operating Expenses and Tax Rate Three months ended Twelve months ended $ in millions December 31, 2021 December 31, 2020 October 2, 2021 December 31, 2021 December 31, 2020 GAAP operating expenses $135.5 $117.6 $124.8 $507.9 $454.3 A
Slide 19: Reconciliation of GAAP Segment Profit to Adjusted Operating Income and Adjusted Segment Profit
Reconciliation of GAAP Segment Profit to Adjusted Operating Income and Adjusted Segment Profit $ in thousands Three Months Ended Twelve months ended Segment profit-GAAP December 31, 2021 December 31, 2020 October 2, 2021 December 31, 2021 December 31, 2020 Specialty Chemicals and Engineered Material
Slide 20: Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA $ in thousands Three Months Ended Twelve months ended December 31, 2021 December 31, 2020 October 2, 2021 December 31, 2021 December 31, 2020 Net sales $635,204 $517,594 $579,493 $2,298,893 $1,859,313 Net income $118,
Slide 21: Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP
Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share $ in thousands, except per share data Three months ended Twelve months ended December 31, 2021 December 31, 2020 October 2, 2021 December 31, 2021 December 31
Slide 22: Reconciliation of GAAP Outlook to Non-GAAP Outlook
Reconciliation of GAAP Outlook to Non-GAAP Outlook $ in millions First-Quarter 2022 Outlook Reconciliation GAAP operating expenses to non-GAAP operating expenses GAAP operating expenses $150 - $152 Adjustments to net income: Restructuring costs 12 Amortization of intangible assets 12 Non-GAAP operat
Slide 23: GAAP Segment Trend Data
GAAP Segment Trend Data $ in thousands Q419 Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Sales SCEM $146,747 $144,214 $146,213 $150,480 $168,625 $166,541 $180,366 $176,380 $188,004 MC 169,794 159,261 183,758 193,541 205,626 207,099 227,521 225,877 258,866 AMH 117,455 116,137 126,434 144,370 151,741 148,5
Slide 24: Non-GAAP Segment Trend Data
Non-GAAP Segment Trend Data $ in thousands Q419 Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Sales SCEM $146,747 $144,214 $146,213 $150,480 $168,625 $166,541 $180,366 $176,380 $188,004 MC 169,794 159,261 183,758 193,451 205,626 207,099 227,521 225,877 258,866 AMH 117,455 116,137 126,434 144,370 151,741 1